Pharmaoffer.com

Buongiorno Ready for the second day at the #CPHI in Milan🇮🇹 Priya Bhat Tânia Marante Liren Zhu Pharmaoffer.com

Attending CPHI Milan? Don't miss the chance to visit Pharmaoffer's Sodium Hyaluronate innovation expert supplier, Shandong Topscience Biotech Co., Ltd. Schedule a meeting with their team to learn how they can provide tailored solutions to help you achieve your business objectives.

We are excited to introduce Valence Labs as one of the newest qualified suppliers on Pharmaoffer. Valence Labs provides cost-effective, high-quality API with GMP-compliant facilities while being committed to meeting the highest regulatory standards in the US, Japan, and the EU. They are also committed to environmental, health, and safety (EHS) compliance. Why Valence Labs? 👉 Advanced R&D operations driving cost-effective production. 👉 A focus on customer-centricity, integrity, and continuous innovation. 👉 A global approach with an eye on expanding into new markets and therapy areas. Discover their product selection and find out how they can meet your API needs by visiting their company page.

I don't know a single company that isn't eager to expand globally. But after attending CPHI Shenzhen 2024, one thing has become crystal clear: the urgency for Chinese pharmaceutical companies to go global has never been more pressing. China's "going global" ambition isn't new. It's been 11 years since the Belt and Road Initiative (BRI) launched, promoting collaboration with over 150 countries. Many Chinese companies have capitalized on this, but 2024 presents new challenges that make international expansion a "now or never" situation. 📉 Involution, or 内卷 The competition in the Chinese domestic market is increasingly severe as it is saturated, leaving little room for growth and squeezing profit margins. Meanwhile, international demand is rising, especially in non-regulated and developing markets where unmet needs present a massive opportunity. 💸 Pressure from within While Chinese public policy pushes for industrial consolidation and innovation, domestic regulations, such as price controls under national health insurance, limit profitability. Expansion is the sole option for many companies now. 🌍 Global landscape shifts We all know geopolitical tensions and trade barriers are complicating international expansion, but other factors exist. High-income countries are also encouraging the reshoring of supply chains to protect their industries. Despite these challenges, companies I spoke with have made strides in international markets, showing significant progress in R&D, biopharma, and API production. However, this progress is only a starting point. What could be the path forward like for companies then? 👉 Having more companies meeting global regulatory standards like FDA, GMP, EMA, etc. 👉 Move beyond "made in China, sold to the world" by establishing overseas subsidiaries, forming joint ventures, and investing in local companies. 👉 Focus on untapped opportunities in Southeast Asia, Brazil, and other regions with unmet pharmaceutical needs. But not every company can do this out of the blue. That's why I believe digital transformation plays a role here. Small and medium-sized companies don't have the resources for large-scale overseas expansion, and digital platforms like Pharmaoffer.com can provide a cost-effective way to break into new markets, allowing companies to reach customers and partners across borders without the heavy upfront investment of physical presence. Whether using digital channels to manage supply chains or not, the momentum for Chinese pharma to expand is already here— we just need to make it count. See you next year Shenzhen! #CPHISHENZHEN #CPHIMILAN #CPHI #API #DIGITALPLATFORM #PHARMAOFFER

At the age of 28, Ammar Badwy began his biopharma-industry journey by creating an online portal that “digitized the sourcing of API.”  He’s now connecting global drug and therapy sponsors to CDMOs for all of the variated development and manufacturing services they provide. Read more from his conversation with Chief Editor Louis Garguilo: https://lnkd.in/ecxQtRBj

Join us in welcoming EVER Pharma (Group) our new CDMO/CMO partner, now on Pharmaoffer. Based in Austria and Germany, with EU GMP-certified facilities and marketing to 70 countries worldwide, EVER Pharma specializes in complex injectables, including high-potency substances and sterile formulations. EVER Pharma stands as a strong contender if you require anything from: 👉 Formulation development to large-scale production, covering everything from clinical trials to global distribution. 👉 Expertise in injectables such as narcotics, hormones, cytotoxics, and others. Discover more about their services by visiting their company page. #pharmaoffer #newsupplier #partnerships #api #b2b #healthtech #pharma

Exciting updates from Pharmaoffer 📰 Exclusive interview with Shilpa Medicare Limited, Ammar's Conversation with Outsourced Pharma, everything you need to know about Pharmaoffer's newest features, and the team getting ready to hit the road. ✈️🌏

Indeed, we do. But at Pharmaoffer we know so much more. Like for example, how to match the most qualified suppliers and buyers together for fruitful and lasting business partnerships. That is why we are heading to Milan. CPHI is celebrating 35 years of uniting pharma, and we are all here for it. After all, this is also our mission. Unity is a pretty big deal for us. We firmly believe that a united market is robust, fair, fast, and the cornerstone of our industry's future. It's what we all strive for. Meet up with our team over gelato. 🍦 #CPHIMilan #PharmaIndustry #Pharmaoffer #API #b2b #healthtech #Pharma #PharmaNetworking #B2BPharma

New feature update 💻 👉 Follow on products. 👉 Follow companies. 👉 Get a notification when that product is available. Remain up to date with partners, competitors, and even your own company with Pharmaoffer.

Our newest feature is one I have been really excited to share. That's because simplifying our customers' supply chain while ensuring there are no disruptions is one of our main goals. So, as of today, our users can follow products and get notified if a new supplier has the product they are interested in. 🎉 But that's not all. Now, all Pharmaoffer.com users can also follow companies. This means they can remain up to date with their current suppliers, competitors, or even the company they work for. This is a significant step in our commitment to keeping our 1.5m yearly pharma users informed with only the information that is relevant and important to them.